http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9885e9ebfcc14d8b2f5f9572d337e9c

Outgoing Links

Predicate Object
family-name Bryant
name Mark Bryant
given-name Mark
organization-name Wound Healing and Tissue Regeneration Program, Endothelial Gene Expression Group, Vascular Diseases Unit, Glaxo-Wellcome Medicines Research Centre, Stevenage, Hertfordshire, SG1 2NY, UK
Dermot Rowe Library, Oxford Learning Disability, United Kingdom.
‡Division of Veterinary Resources, Office of Research Services, National Institutes of Health, Bethesda, MD 20892; and
2Veterinary Resources Program/Office of the Director, National Institutes of Health, Bethesda, MD 20892
Division of Veterinary Resources, Office of Research Services, Bethesda, MD, USA
Health Care Practice Group of Polsinelli, Shalton & Welte, P.C. Kansas City, Missouri, USA.

Incoming Links

Predicate Subject
creator http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10676196
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22716248
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3861914
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21481385
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11123783
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14063563
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25655799
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22870412
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3184405
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11221065
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27667146
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21369121
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7354152
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21308275
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22703281
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7816540
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7335554
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24116839
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/204245468
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/219474
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31629554

Total number of triples: 30.